Published in Ann R Coll Surg Engl on July 01, 1997
Interval cancers in the Dutch breast cancer screening programme. Br J Cancer (1999) 1.18
Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst (1982) 13.25
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet (1984) 10.22
Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet (1993) 9.88
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet (1990) 6.17
National Health Service breast screening programme results for 1991-2. BMJ (1993) 5.79
Breast screening: time for a rethink? BMJ (1989) 5.52
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Screening mammography and public health policy: the need for perspective. Lancet (1995) 5.12
Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ (1995) 4.83
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ (1995) 3.65
The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer (1993) 2.88
The efficacy of double reading mammograms in breast screening. Clin Radiol (1994) 2.60
Screening for breast cancer, time to think--and stop? Lancet (1995) 2.58
What should be done about interval breast cancers? BMJ (1995) 2.55
Number of projections in mammography: influence on detection of breast disease. AJR Am J Roentgenol (1978) 2.44
Screening for breast cancer detects tumours at an earlier biological stage. Br J Surg (1993) 2.16
The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer (1989) 1.94
Breast cancer detection: one versus two views. Radiology (1987) 1.82
Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat (1987) 1.78
Double reading of mammography screening films--one radiologist or two? Clin Radiol (1993) 1.69
Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme. Ann R Coll Surg Engl (1993) 1.05
Population breast cancer screening: theory, practice, and service implications. Lancet (1995) 0.99
Results of the first year of breast cancer screening in a district hospital. Br J Surg (1992) 0.82
Screening for breast cancer. Br J Surg (1993) 0.78
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet (1987) 4.28
Marking planes of surgical excision on breast biopsy specimens: use of artists' pigments suspended in acetone. J Clin Pathol (1988) 3.41
Starch granulomatosis of the peritoneum. Br Med J (1971) 3.38
Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues. J Cell Sci (2001) 3.24
Lysozyme is a component of human vascular elastic fibers. Experientia (1983) 2.88
Fine needle aspiration cytology. J Clin Pathol (1985) 2.71
Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet (1985) 2.44
Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg (1993) 2.09
Mammary duct ectasia--periductal mastitis complex. Br J Surg (1995) 2.06
Laboratory handling of impalpable breast lesions: a review. J Clin Pathol (1991) 2.04
The diagnostic cytology of breast carcinoma. Br J Surg (1970) 2.00
'Diamond-shaped' crypts and mucosal elastin: helpful diagnostic features in biopsies of rectal prolapse. Histopathology (1990) 1.98
The response of general surgeons to HIV in England and Wales. Ann R Coll Surg Engl (1990) 1.89
Differential marking of excision planes in screened breast lesions by organically coloured gelatins. J Clin Pathol (1990) 1.80
Separate effects of freezing, thawing and drying living cells. Ann N Y Acad Sci (1965) 1.80
Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev (1996) 1.77
A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer (2000) 1.71
Some factors affecting the viability of freeze-thawed T4 bacteriophage. J Hyg (Lond) (1969) 1.68
Pierre Vernier's invention: a neglected tool of our trade. Histopathology (1991) 1.67
Natural history of the benign breast lump. Br J Surg (1988) 1.65
Malignant retroperitoneal fibrosis. Br J Surg (1967) 1.64
Modern aids to clinical decision-making in the acute abdomen. Br J Surg (1990) 1.63
Respiratory disease associated with practolol therapy. Lancet (1977) 1.61
Review of the management of recurrent inguinal hernia. Hernia (2003) 1.60
Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer (1988) 1.59
The clinical syndrome of mammary duct ectasia. Br J Surg (1982) 1.57
Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J (Clin Res Ed) (1987) 1.57
Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer (1994) 1.54
Hyperkalaemic cardiac arrhythmia caused by potassium citrate mixture. Br Med J (Clin Res Ed) (1982) 1.53
Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg (1980) 1.51
Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor. Eur J Immunol (1986) 1.47
Primary breast lymphoma with skin involvement arising in lymphocytic lobulitis. Histopathology (1994) 1.45
Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management. Br J Surg (1977) 1.45
Familial breast cancer. J R Coll Surg Edinb (1991) 1.43
Small bowel transit time in patients with intra-abdominal adhesions. Br J Surg (1992) 1.43
pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer (1991) 1.43
Sulphasalazine hepatotoxicity after 15 years' successful treatment for ulcerative colitis. Br Med J (Clin Res Ed) (1983) 1.42
The diagnosis and management of mixed arterial/venous leg ulcers in community-based clinics. Eur J Vasc Endovasc Surg (1998) 1.41
Patient's understanding of clinical trials. Lancet (1998) 1.41
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol (1985) 1.41
Technique for closure of port sites under laparoscopic visual control. Br J Surg (1995) 1.39
The halothane test: a practical method of eliminating porcine stress syndrome. Vet Rec (1981) 1.38
Exfoliative cytology in the diagnosis of breast disease. Br J Surg (1995) 1.38
Backprocessing paraffin wax blocks for subgross examination. J Clin Pathol (1992) 1.38
Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet (1989) 1.37
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. Br J Cancer (1988) 1.37
Acalculous biliary pain: diagnosis and selection for cholecystectomy using the cholecystokinin test for pain reproduction. Br J Surg (1984) 1.36
Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen. Clin Exp Immunol (1983) 1.34
Dieulafoy's disease: a distinctive arteriovenous malformation causing massive gastric haemorrhage. Br J Surg (1983) 1.29
Phaeochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results. Br J Surg (1979) 1.29
Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers. Q J Med (1977) 1.29
A 30-minute preparative method for isolation of IgG from human serum. Vox Sang (1972) 1.28
Behçet's syndrome with haemoptysis and pulmonary lesions. J Pathol (1973) 1.28
The histopathology of peritoneal starch granulomas. J Pathol (1972) 1.27
Diazoxide in the management of patients with insulinoma. World J Surg (1986) 1.27
Prospective evaluation of magnetic resonance cholangiography to detect common bile duct stones before laparoscopic cholecystectomy. Br J Surg (1998) 1.26
Newly synthesized elastin is associated with neoplastic epithelial cells in human mammary carcinoma. Experientia (1980) 1.25
Cholecystokinin (CCK) provocation test: long-term follow-up after cholecystectomy. Br J Surg (1988) 1.24
Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg (1986) 1.24
Some factors affecting the viability of freeze-thawed T4 bacteriophage. II. The influence of certain electrolytes on the degree of inactivation. J Hyg (Lond) (1969) 1.22
Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J Steroid Biochem Mol Biol (1990) 1.22
Fine-needle aspiration biopsy and the diagnosis of thyroid cancer. Br J Surg (1987) 1.22
Epidermal growth factor receptors on human breast cancers. Br J Surg (1985) 1.21
Smooth muscle proliferation in the hilum of superficial lymph nodes. Virchows Arch A Pathol Anat Histopathol (1985) 1.21
Quality of life measurement in patients with oesophageal cancer. Gut (1995) 1.21
Surgery for benign insulinoma: an international review. World J Surg (1990) 1.21
A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem (2001) 1.19
A comparison of reports from referees chosen by authors or journal editors in the peer review process. Ann R Coll Surg Engl (2000) 1.17
Diagnosis of granulomatous starch peritonitis by delayed hypersensitivity skin reactions. Br J Surg (1982) 1.17
Adenolymphoma of the parotid: aetiology, diagnosis and treatment. Br J Surg (1986) 1.15
Gall bladder function after endoscopic sphincterotomy. BMJ (1990) 1.14
Parathyroid disease and calcium metabolism. Br J Anaesth (2000) 1.13
Lymph-node infarction and malignant lymphoma: a multicentre survey of European, English and American cases. Histopathology (1986) 1.12
Allergic starch peritonitis in the guinea-pig. Br J Surg (1976) 1.12
Non-nuclear staining of thick tissue sections. J Clin Pathol (1993) 1.12
The second example of anti-Doa. Vox Sang (1967) 1.11
Plexiform vascularization of lymph nodes: an unusual but distinctive lymphadenopathy in cats. J Comp Pathol (1987) 1.10
Laminin and fibronectin in adenoid cystic carcinoma. J Clin Pathol (1986) 1.09
Five-year prospective follow-up of 430 laparoscopic totally extraperitoneal inguinal hernia repairs in 275 patients. Ann R Coll Surg Engl (2010) 1.09
Measurement of oestrogen receptor mRNA levels in human breast tumours. Br J Cancer (1988) 1.08
Early gastric cancer: the case for long term surveillance. Br Med J (Clin Res Ed) (1985) 1.08
The clinical features and treatment of fetus in fetu: two case reports and a review of the literature. J Pediatr Surg (1975) 1.07
Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling. Immunology (1987) 1.06
Oleocysts presenting as rectal tumours. Br J Surg (1966) 1.06
Use of fine needle aspiration cytology with immediate reporting in the diagnosis of breast disease. Br J Surg (1988) 1.06
Superficial carcinoma of the stomach. Br Med J (1976) 1.06
Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation (2002) 1.06
Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer (1996) 1.05
Inorganic nitrate and the cardiovascular system. Heart (2010) 1.04
Spontaneous infarction of superficial lymph nodes. J Clin Pathol (1972) 1.04
Parathyroidectomy in chronic renal failure: a nine-year follow-up study. Q J Med (1990) 1.03
Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer (1991) 1.03
Cytologic diagnosis of salivary gland lesions in adult and pediatric surgical patients. Acta Cytol (1973) 1.03
Starch dermatitis: evidence of immunogenicity of surgical glove powder in the guinea-pig. Br J Exp Pathol (1975) 1.03
Hyperelastosis, obliteration and fibrous plaques in major ducts of the human breast. J Pathol (1973) 1.02
Observer variation in assessment of quality of life in patients with oesophageal cancer. Br J Surg (1995) 1.01